Monoclonal Antibodies Preserve Stem Cells in Mouse Brains, Bring Promise for Future Studies

November 9, 2022


Read time:

5-15 mins
Brain Stem Blue Green Slice
Presented by Health Lab

A new Michigan Medicine study suggests a new approach to stem cell therapy that uses antibodies instead of traditional immunosuppressant drugs to help preserves cells in mouse brains and has the potential for human trials in the future. Revealed that suppression with monoclonal antibodies enabled long-term survival of human stem cell transplants can help others. Kevin Chen, M.D., a neurosurgeon at the University of Michigan Health and clinical assistant professor of neurosurgery at U-M Medical School, discusses how the collection of experiments lays the groundwork for understanding how transplanted stem cells would integrate with the brain.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.